Reaction
Sacral Pain reporting signals
As of the last recalculation, Sacral Pain appears in 585 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is KETOPROFEN (PRR 53.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ketoprofen | 19 | 53.2 | 53.3 |
| Magnesium Sulfate In Water For | 11 | 31.2 | 31.2 |
| Magnesium Sulfate Heptahydrate | 11 | 30.6 | 30.6 |
| Magnesium Sulfate | 11 | 30.5 | 30.6 |
| Pitavastatin Calcium | 8 | 28.2 | 28.2 |
| Cladribine | 7 | 26.2 | 26.2 |
| Secukinumab | 79 | 20.0 | 20.0 |
| Botulinum Toxin Type A | 6 | 17.4 | 17.4 |
| Ocrelizumab | 28 | 16.8 | 16.8 |
| Abaloparatide | 11 | 13.5 | 13.5 |
| Romosozumab-Aqqg | 5 | 13.2 | 13.2 |
| Trifluridine And Tipiracil | 3 | 10.0 | 10.0 |
| Ixekizumab | 9 | 8.8 | 8.8 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 3 | 8.1 | 8.1 |
| Nirmatrelvir And Ritonavir | 8 | 5.3 | 5.3 |